MTHFR and COVID-19: Focusing on methionine metabolism, we found that combining MTHFR genetic polymorphism data with plasma methionine cycle biomarkers predicts COVID-19 severity and long COVID risk, offering an accessible molecular axis for potential early clinical risk assessment.